Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Personal

XORTX Initiates Precision Medicine Program

Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine Metabolism CALGARY, Alberta, Oct. 09, 2024 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Co

By: financialpost.com

Oct 09 2024
0
0 Views

Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine Metabolism Read More

Related

VIQ Solutions Announces Transformative Q3 2024: Significant Growth in Adjusted EBITDA

Murchinson Issues Presentation Detailing Urgent Need for Boardroom Change in Order to Save Nano Dimension

Dream Unlimited Corp. Reports Third Quarter Results

Viridian Metals Announces Opening of Trading on TSX Venture Exchange on November 14, 2024

Korea Zinc to Decide on Disputed $1.8 Billion Share Plan As Pressure Rises

Zefiro Methane Corp. Chief Commercial Officer to Serve as Featured Speaker at United Nations COP29

DATA Communications Management Corp. Announces Third Quarter 2024 Financial Results

Mexico Budget Plans to Include $6 Billion Support for Pemex Debt

Finning reports Q3 2024 results

Extendicare Announces 2024 Third Quarter Results and Early Redemption of 2025 Debentures

Xtract One Announces Results of Voting at the Annual General Meeting of Shareholders

Orca Announces Quarterly Dividend

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

Next

VIQ Solutions Announces Transformative Q3 2024: Significant Growth in Adjusted EBITDA